Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Letrozole MeSH Descriptor Data 2026


MeSH Heading
Letrozole
Tree Number(s)
D02.626.300
D03.383.129.799.638
Unique ID
D000077289
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077289
Scope Note
A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women.
Entry Term(s)
4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile)
CGS 20267
CGS-20267
Femara
Fémara
Pharm Action
Antineoplastic Agents
Aromatase Inhibitors
Registry Numbers
7LKK855W8I
0
Related Numbers
112809-51-5
CAS Type 1 Name
Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-
Public MeSH Note
2019; LETROZOLE was indexed under NITRILES and TRIAZOLES 1991-2018
History Note
2019 (1991)
Date Introduced
2019/01/01
Last Updated
2019/01/01
Letrozole Preferred
CGS 20267 Narrower
Femara Narrower
page delivered in 0.125s